Form 4: Cardlytics CFO Alexis DeSieno Sells Shares to Cover Tax Obligations After RSU Vesting
SEC Form 4 Filing
Cardlytics' Chief Financial Officer, Alexis DeSieno, sold 25,118 shares of common stock to cover tax obligations following the vesting of restricted stock units.
Summary
- Alexis DeSieno, the Chief Financial Officer of Cardlytics, Inc., engaged in transactions involving the company's stock.
- On November 14, 2024, 43,750 restricted stock units (RSUs) vested, each representing a contingent right to receive one share of common stock.
- Following the vesting, on November 15, 2024, DeSieno sold 25,118 shares of common stock at a weighted average price of $3.43 per share.
- The sale was solely to satisfy withholding tax obligations resulting from the delivery of shares for the vested RSUs.
- The CFO did not sell shares for any other purpose.
- After these transactions, DeSieno directly owns 116,481 shares of Cardlytics common stock.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to executive compensation. There is no indication of positive or negative sentiment, it is a standard procedure.
Industry Context
This is a routine transaction for a company executive, where shares are sold to cover tax obligations after the vesting of stock-based compensation. It is common practice and does not necessarily indicate a change in the executive's outlook on the company's future.
Comparison to Industry Standards
- Similar transactions are common among executives at publicly traded companies, particularly after vesting of stock options or restricted stock units.
- The sale of shares to cover tax obligations is a standard practice and does not indicate any unusual activity compared to other companies.
Stakeholder Impact
- The sale of shares by the CFO may have a minor impact on the stock price, but it is unlikely to be significant given the routine nature of the transaction.
Key Dates
| Date | Description |
|---|---|
| 11/14/2024 | 43,750 restricted stock units (RSUs) vested. |
| 11/15/2024 | 25,118 shares of common stock were sold to cover tax obligations. |
Keywords
Cardlytics, CFO, Alexis DeSieno, stock sale, restricted stock units, RSU, tax obligations, insider trading, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.